Covid 19: Hydroxychloroquine for the Early Treatment of COVID-19 in Hospitalized Adults: A Multicenter Randomized Clinical Trial (PETAL Network Study)

Pharmacology, Toxicology and Pharmaceutical Science

1. Randomized Clinical Trial 100%
2. Hydroxychloroquine 100%
3. Clinical Trial 20%
4. Human Study 20%
5. Antivirus Agent 20%
6. SARS Coronavirus 20%
7. Antiinfective Agent 20%
8. Placebo 20%
9. Antimicrobial Agent 20%